Circulating Tumor Cells, from Biotech Innovation to Clinical Utility Part a

Volume 381

• Gebundenes Buch

Produktbeschreibung

"Circulating Tumor Cells, from biotech innovation to clinical utility" provides an overview of the most recent technological and clinical advances with regards to the study of circulating tumor cells (CTCs) in solid tumors. The volumes cover studies on CTCs in breast, prostate, colorectal and lung cancer, with a focus on clinical utility, and also include methodological and biological topics such as CTC culture, multi-omic characterization of CTCs, atypical CTC populations and interaction between CTCs and immunity.

Produktdetails

• Verlag: Elsevier Health Sciences
• Seitenzahl: 174
• Erscheinungstermin: 19. September 2023
• Englisch
• Gewicht: 450g
• ISBN-13: 9780443161346
• ISBN-10: 0443161348
• Artikelnr.: 68168677

Inhaltsangabe

1. Latest advances in clinical studies of circulating tumor cells in early and metastatic breast cancer Laura S. Munoz-Arcos
Eleonora Nicolò
Mara S. Serafini
Lorenzo Gerratana
Carolina Reduzzi
and Massimo Cristofanilli 2. Can we define breast cancer HER2 status of by liquid biopsy? Serena Di Cosimo
Cinzia De Marco
Marco Silvestri
Adele Busico
Andrea Vingiani
Giancarlo Pruneri
and Vera Cappelletti 3. Models to study CTCs and CTC culture methods Cristóbal Fernández-Santiago
Rafael López-López
and Roberto Piñeiro Cid 4. Settling the uncertainty about unconventional circulating tumor cells: epithelial-to-mesenchymal transition
cell fusion and trogocytosis Giulia Gallerani
Tania Rossi
Manuela Ferracin
and Massimiliano Bonafè 5. Circulating tumor cells in cancer-risk populations as a cancer interception tool María José Serrano
Christian Rolfo
José Expósito-Hernandez
Carmen Garrido-Navas
José Javier Lopez-Hidalgo
and Valeria Denninghoff 6. Circulating tumor cells and host immunity: a tricky liaison Elena Muraro and Giulia Brisotto